• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Microsoft Deploys COVID-19 Vaccine Management Platform

Share:

December 22, 2020

Highlights on this story:
  • Microsoft launches a COVID-19 vaccine management platform with partners Accenture and Avanade, EY, and Mazik Global to help government and healthcare customers provide fair and equitable vaccine distribution, administration, and monitoring of vaccine delivery.
  • Microsoft Consulting Services (MCS) has deployed over 230 emergency COVID-19 response missions globally since the pandemic began in March, including recent engagements to ensure the equitable, secure and efficient distribution of the COVID-19 vaccine.

With COVID-19 vaccines soon to be available, Microsoft announced it has launched a COVID-19 vaccine management platform together with industry partners Accenture, Avandae, EY, and Mazik Global. The COVID-19 vaccine management solutions will enable registration capabilities for patients and providers, phased scheduling for vaccinations, streamlined reporting, and management dashboarding with analytics and forecasting.

These offerings are helping public health agencies and healthcare providers to deliver the COVID-19 vaccine to individuals in an efficient, equitable and safe manner. The underlying technologies and approach have been tested and deployed with prior COVID-19 use cases, including contact tracing, COVID-19 testing, and return to work and return to school programs.

To date, Microsoft Consulting Services (MCS) has deployed over 230 emergency COVID-19 response missions globally since the pandemic began in March, including recent engagements to ensure the equitable, secure and efficient distribution of the COVID-19 vaccine. MCS has developed an offering, the Vaccination Registration and Administration Solution (VRAS), which advances the capabilities of their COVID-19 solution portfolio and enables compliant administration of resident assessment, registration and phased scheduling for vaccine distribution.

Key features of the solutions include:

– tracking and reporting of immunization progress through secure data exchange that utilizes industry standards, such as Health Level Seven (HL7), Fast Healthcare Interoperability Resources (FHIR) and open APIs.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– health providers and pharmacies can monitor and report on the effectiveness of specific vaccine batches, and health administrators can easily summarize the achievement of vaccine deployment goals in large population groups

Partnership Offerings

Microsoft partners have leveraged the Microsoft cloud to provide customers with additional offerings to support vaccine management. These offerings also apply APIs, HL7 and FHIR to enable interoperability and integration with existing systems of record, artificial intelligence to generate accurate and geo-specific predictive analytics, and secure communications using Microsoft Teams.

– EY has partnered with Microsoft for the EY Vaccine Management Solution to enable patient-provider engagement, supply chain visibility, and Internet of Things (IoT) real-time monitoring of the vaccines. Additionally, the EY Vaccine Analytics Solution is an integrated COVID-19 data and analytics tool supporting stakeholders in understanding population and geography-specific vaccine uptake.

Mazik Global has created the MazikCare Vaccine Flow that is built on Power Apps and utilizes pre-built templates to implement scalable solutions to accelerate the mass distribution of the COVID-19 vaccine. Providers will be able to seek out specific populations based on at-risk criteria to prioritize distribution. Patients can self-monitor and have peace of mind to head-off adverse reactions.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Delayed Nhs Medtech Funding Mandate Policy to Launch in AprilDelayed Nhs Medtech Funding Mandate Policy to Launch in April
  • Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital HealthCerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health
  • Digital Diabetes Market to Reach $1.5B by 2024, Research FindsDigital Diabetes Market to Reach $1.5B by 2024, Research Finds
  • AbbVie, Tolero team up to test Venclexta combo in AMLAbbVie, Tolero team up to test Venclexta combo in AML
  • Deloitte’s Gebreyes: ’Health Equity is a Moral Imperative That Requires a Business Solution’Deloitte’s Gebreyes: ’Health Equity is a Moral Imperative That Requires a Business Solution’
  • World’s first AI-Powered Rapid COVID-19 Antigen Test Launched in the UAEWorld’s first AI-Powered Rapid COVID-19 Antigen Test Launched in the UAE
  • Fujifilm India Introduces AI Software for COVID-19 Pneumonia DiagnosisFujifilm India Introduces AI Software for COVID-19 Pneumonia Diagnosis
  • C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence PlatformC2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications